Sunshine Biopharma (SBFM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.22, -3.57% vs the prior close of $0.23.
- Volume 877.07K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SBFM slides 3.6% to $0.22, a 52-week low. Closed at $0.22, -3.57% vs the prior close of $0.23. Day range $0.20–$0.23, opened at $0.22.
SBFM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SBFM slides 3.6% to $0.22, a 52-week low
- Closed at $0.22, -3.57% vs the prior close of $0.23. Day range $0.20–$0.23, opened at $0.22.
- Volume was 877.07K shares, 0.1x its 50-day average of 6.98M — lighter than usual.
- Price is -75.6% vs its 50-day average ($0.91) and -96.4% vs its 200-day average ($6.09).
- 52-week range $0.19–$24.30; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 15, 2026 — SBFM slides 5.3% to $0.23, a 52-week low
- Closed at $0.23, -5.35% vs the prior close of $0.24. Day range $0.19–$0.23, opened at $0.23.
- Volume was 1.57M shares, 0.2x its 50-day average of 6.95M — lighter than usual.
- Price is -75.3% vs its 50-day average ($0.93) and -96.3% vs its 200-day average ($6.15).
- 52-week range $0.19–$24.30; today's close sits at 0% of that range, 99.1% below the 52-week high.
Oct 14, 2026 — SBFM rises 3.0% to $0.24
- Closed at $0.24, +2.97% vs the prior close of $0.24. Day range $0.21–$0.25, opened at $0.23.
- Volume was 1.74M shares, 0.2x its 50-day average of 6.97M — lighter than usual.
- Price is -74.6% vs its 50-day average ($0.95) and -96.1% vs its 200-day average ($6.21).
- 52-week range $0.21–$24.30; today's close sits at 0% of that range, 99.0% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — SBFM slides 21.9% to $0.24, a 52-week low, 4 down days in a row
- Closed at $0.24, -21.85% vs the prior close of $0.30. Day range $0.23–$0.30, opened at $0.29.
- Volume was 4.85M shares, 0.7x its 50-day average of 6.87M.
- Price is -75.8% vs its 50-day average ($0.98) and -96.2% vs its 200-day average ($6.28).
- 52-week range $0.23–$24.30; today's close sits at 0% of that range, 99.0% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — SBFM slides 10.7% to $0.30, a 52-week low, 3 down days in a row
- Closed at $0.30, -10.65% vs the prior close of $0.34. Day range $0.28–$0.33, opened at $0.31.
- Volume was 2.47M shares, 0.4x its 50-day average of 6.82M — lighter than usual.
- Price is -69.6% vs its 50-day average ($0.99) and -95.2% vs its 200-day average ($6.34).
- 52-week range $0.28–$24.30; today's close sits at 0% of that range, 98.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — SBFM slides 21.4% to $0.34, a 52-week low
- Closed at $0.34, -21.40% vs the prior close of $0.43. Day range $0.33–$0.40, opened at $0.40.
- Volume was 6.95M shares, 1.0x its 50-day average of 6.71M.
- Price is -66.6% vs its 50-day average ($1.01) and -94.7% vs its 200-day average ($6.40).
- 52-week range $0.33–$24.30; today's close sits at 0% of that range, 98.6% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 — SBFM slides 38.6% to $0.43 on 27.3x normal volume
- Closed at $0.43, -38.57% vs the prior close of $0.70. Day range $0.38–$0.47, opened at $0.47.
- Volume was 118.47M shares, 27.3x its 50-day average of 4.34M — unusually heavy trading.
- Price is -58.3% vs its 50-day average ($1.03) and -93.4% vs its 200-day average ($6.47).
- 52-week range $0.36–$24.30; today's close sits at 0% of that range, 98.2% below the 52-week high.
Oct 7, 2026 — SBFM jumps 75.9% to $0.70 on 227.4x normal volume
- Closed at $0.70, +75.88% vs the prior close of $0.40. Day range $0.40–$1.56, opened at $0.41.
- Volume was 177.96M shares, 227.4x its 50-day average of 782.54K — unusually heavy trading.
- Price is -33.1% vs its 50-day average ($1.05) and -89.3% vs its 200-day average ($6.54).
- 52-week range $0.36–$24.30; today's close sits at 1% of that range, 97.1% below the 52-week high.
Oct 6, 2026 — SBFM slides 5.2% to $0.40, a 52-week low on 6.5x normal volume
- Closed at $0.40, -5.24% vs the prior close of $0.42. Day range $0.36–$0.43, opened at $0.43.
- Volume was 4.52M shares, 6.5x its 50-day average of 693.66K — unusually heavy trading.
- Price is -62.5% vs its 50-day average ($1.06) and -94.0% vs its 200-day average ($6.60).
- 52-week range $0.36–$24.30; today's close sits at 0% of that range, 98.4% below the 52-week high.
- That makes 7 straight losses.
Oct 5, 2026 — SBFM slides 37.0% to $0.42, a 52-week low on 3.3x normal volume
- Closed at $0.42, -37.03% vs the prior close of $0.67. Day range $0.41–$0.50, opened at $0.49.
- Volume was 2.13M shares, 3.3x its 50-day average of 651.52K — unusually heavy trading.
- Price is -61.2% vs its 50-day average ($1.08) and -93.7% vs its 200-day average ($6.67).
- 52-week range $0.41–$24.30; today's close sits at 0% of that range, 98.3% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — SBFM slides 3.1% to $0.67, a 52-week low, 5 down days in a row
- Closed at $0.67, -3.05% vs the prior close of $0.69. Day range $0.67–$0.75, opened at $0.71.
- Volume was 149.40K shares, 0.2x its 50-day average of 649.12K — lighter than usual.
- Price is -39.8% vs its 50-day average ($1.11) and -90.1% vs its 200-day average ($6.74).
- 52-week range $0.67–$24.30; today's close sits at 0% of that range, 97.3% below the 52-week high.
- That makes 5 straight losses.
- SEC filings that day: S-1.
SBFM latest news & SEC filings
Every SEC filing by or about SBFM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form PRE 14C — PRE 14C filing
PRE 14C filing
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Oct 9, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 5, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 2, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 28, 2026 · Form DEF 14C — DEF 14C filing
DEF 14C filing
Sep 16, 2026 · Form PRE 14C — PRE 14C filing
PRE 14C filing
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade SBFM
- Last results release: Apr 9, 2026 (8-K Item 2.02). Previous ones: May 19, 2025, Apr 2, 2025, Nov 7, 2024. Based on that rhythm, the next report is likely around Jul 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 13.19% (largest 75.9%). That is a volatile stock.
- Liquidity: about 16.15M shares (≈$3.58M) trade per day on average.
- 52-week position: $0.22 vs a range of $0.19–$24.30 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Jun 1, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 9, 2026; 8-K Sep 16, 2026.
- Share count: 3.88M shares outstanding (Aug 13, 2026), -14.9% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
SBFM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.22 | 0.23 | 0.20 | 0.22 | 877.07K |
| Oct 15, 2026 | 0.23 | 0.23 | 0.19 | 0.23 | 1.57M |
| Oct 14, 2026 | 0.23 | 0.25 | 0.21 | 0.24 | 1.74M |
| Oct 13, 2026 | 0.29 | 0.30 | 0.23 | 0.24 | 4.85M |
| Oct 12, 2026 | 0.31 | 0.33 | 0.28 | 0.30 | 2.47M |
| Oct 9, 2026 | 0.40 | 0.40 | 0.33 | 0.34 | 6.95M |
| Oct 8, 2026 | 0.47 | 0.47 | 0.38 | 0.43 | 118.47M |
| Oct 7, 2026 | 0.41 | 1.56 | 0.40 | 0.70 | 177.96M |
| Oct 6, 2026 | 0.43 | 0.43 | 0.36 | 0.40 | 4.52M |
| Oct 5, 2026 | 0.49 | 0.50 | 0.41 | 0.42 | 2.13M |
| Oct 2, 2026 | 0.71 | 0.75 | 0.67 | 0.67 | 149.40K |
| Oct 1, 2026 | 0.78 | 0.78 | 0.67 | 0.69 | 131.80K |
| Sep 30, 2026 | 0.81 | 0.83 | 0.77 | 0.77 | 47.20K |
| Sep 29, 2026 | 0.81 | 0.81 | 0.78 | 0.79 | 38.00K |
| Sep 28, 2026 | 0.84 | 0.85 | 0.82 | 0.82 | 37.40K |
| Sep 25, 2026 | 0.84 | 0.86 | 0.80 | 0.84 | 131.50K |
| Sep 24, 2026 | 0.87 | 0.88 | 0.78 | 0.80 | 190.50K |
| Sep 23, 2026 | 0.90 | 0.93 | 0.87 | 0.88 | 94.60K |
| Sep 22, 2026 | 0.93 | 0.96 | 0.86 | 0.91 | 400.10K |
| Sep 21, 2026 | 0.89 | 0.97 | 0.86 | 0.91 | 219.20K |
About Sunshine Biopharma
Sunshine Biopharma (SBFM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in FORT LAUDERDALE, FL. State of incorporation: CO. Fiscal year ends December 31. SEC CIK 1402328.
SBFM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David Natan | Director | Aug 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SBFM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $36.31M | $-5.98M | — | $-5.33M |
| Dec 31, 2024 | $34.87M | $-5.13M | -7.32 | $-12.52M |
| Dec 31, 2023 | $24.09M | $-4.51M | -351.36 | $-8.78M |
| Dec 31, 2022 | $4.35M | $-26.74M | -1.76 | $-5.25M |
| Dec 31, 2021 | $228.43K | $-12.44M | -4.76 | $-1.83M |
Latest balance sheet: total assets $33.63M, total liabilities $6.09M, cash $19.73M (as of Jun 30, 2026).
SBFM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Apr 9, 2026 | 8-K Item 2.02 (results) | $10.40 |
| May 19, 2025 | 8-K Item 2.02 (results) | $14.90 |
| Apr 2, 2025 | 8-K Item 2.02 (results) | $22.50 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $27.20 |
| Aug 19, 2024 | 8-K Item 2.02 (results) | — |
| May 22, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
| Aug 11, 2023 | 8-K Item 2.02 (results) | — |
| May 11, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SBFM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.